Earlier this year, Akorn Pharmaceuticals fell into bankruptcy, and now an alliance of stakeholders have released a report outlining potential supply disruption to a number of medications.
This capsule of industry news features Amcor, High Purity New England, MG America, and other firms offering packaging and labeling products and services.
The temporary medicines unit built for the agency's Central Intravenous Additive Service can produce up to 2,600 syringes weekly to meet growing demand
While the prevalence of chronic diseases boosts the demand for self-administered treatments, ease of use is becoming more important in device manufacturing, says product specialist.
Aptar Pharma has formed an alliance with Becton, Dickinson & Co to develop new self-injection devices that will tap into the strong growth in injectable drugs.
Hikma invested over $25m in its US facilities in the first half 2016, and plans to use excess capacity at a former Boehringer Ingelheim plant for contract manufacturing.
BD says its new quality by design glass prefillable syringe offers added safety in delivering biologics as the industry continues to shift toward biotechnology.
Immunotherapy and vaccine specialist Circassia says its new license agreement with NanoPass Technologies will help its range of allergy products to thrive on the market.
West Pharmaceutical Services is preparing to increase its manufacturing capacity in response to an increased demand for its Daikyo Crystal Zenith 1mL syringe system.
Unilife has initiated a 24/7 manufacturing cycle at its facility at Lewisberry, Pennsylvania, US after it received marketing clearance for its Unitract 1ml insulin syringes from the US FDA.
The US arm of packaging giant Schott has added ready-to-fill (RTF) glass syringe manufacturing capacity at its facility in Lebanon, Pennsylvania in a $14m (€9.4m) expansion designed to meet growing demand.
Covidien is recalling half a million ReliOn single-use insulin syringes after it was uncovered that some had been mislabelled, creating the potential for fatal overdose.
The world's number two manufacturer of rubber components for
pharmaceutical products, Helvoet Pharma, has broken ground on a new
facility that promises to double or even triple its capacity to
supply the fast-growing markets...
Gerresheimer has announced it will launch a new plastic syringe
range in January to cater for highly-sensitive medications and also
for high-volume injections.
The convenience of non-invasive insulin delivery methods is set to
overcome their high cost and concerns about safety and efficacy,
with the greatest beneficiary being the European inhaled insulin
market which is predicted to swell...
West Pharmaceutical Services has reported a huge surge in both
sales and profits for its second quarter, spurred on by the
increasing demand for injectable drugs as well as the lucrative
Exubera manufacturing contract, which helped...
The insulin delivery devices thriving in today's market will slowly
be replaced as new and better technologies continue to rise from
the R&D pipeline. For current market leader, Novo Nordisk, this
threat is particularly dangerous.
A patent covering a simple design for a safety syringe, which uses
a vacuum rather than a spring to retract the needle after use and
should be cheaper to manufacture than current products, has been
filed in the US by Maxxon Inc.
Gerresheimer launched a crop of new pharmaceutical components at
the Interpack show last week, including a new system for the dosing
of water-soluble dry medications and new devices to improve the
safety and ease of use of its syringe...
The market for retractable syringes designed to prevent needlestick
injuries is set for explosive growth and could expand nearly
seven-fold by 2006, according to a new report.